AffaMed Technologies Announces the First Implantation in the China Registrational Clinical Trial of MINI WELL®, the Progressive Extended Depth-of-Focus IOL

SHANGHAI, March 3, 2023 /PRNewswire/ — AffaMed Technologies (“AffaMed”), a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced the completion of the first patient implantation in the Registrational Clinical Trial of its MINI WELL® progressive Extended Depth-of-Focus

Read More

MQDC Idyllias Launches as a “Metta-Verse for All Life Visible”, The World’s First Fully Bridged Reality and Wonders, Bringing Sustainability for All

BANGKOK, March 3, 2023 /PRNewswire/ — MQDC, the leading property developer, has unveiled MQDC Idyllias, the first metaverse bridging the real and virtual worlds to create a new future where all life coexists in well-being, kindness, equality, sustainability, and innovation. MQDC Idyllias

Read More